论文部分内容阅读
目的:对比分析Dox、AMI治疗哮喘患者的临床效果。方法:将2015.1-2016.6收治的113例哮喘患者作为研究对象,将113例分为Dox组、AMI组,Dox组59例,AMI组54例,对比Dox组、AMI组的疗效、症状及血清ERP、ESP水平变化情况。结果:AMI组有效率为79.63%,Dox组为93.22%,AMI组有效率明显低于Dox组;AMI组哮喘症状的持续时间较长,与Dox组比较差异显著;治疗前两组的血清CRP值、血清ESR值无显著差异,治疗后AMI组的血清CRP值、血清ESR值均明显高于Dox组。结论:Dox治疗哮喘的疗效优于AMI。
Objective: To compare and analyze the clinical effect of Dox and AMI in the treatment of asthma patients. Methods: A total of 113 asthma patients admitted from 2015.1-2016.6 were divided into Dox group, 59 cases in AMI group, Dox group and 54 cases in AMI group. The therapeutic effects, symptoms and serum ERP in Dox group and AMI group were compared , ESP level changes. Results: The effective rate was 79.63% in AMI group and 93.22% in Dox group. The effective rate in AMI group was significantly lower than that in Dox group. The duration of asthma symptoms in AMI group was longer than that in Dox group. The levels of CRP Values, serum ESR values no significant difference in AMI group after treatment serum CRP value, serum ESR values were significantly higher than the Dox group. Conclusion: Dox is superior to AMI in the treatment of asthma.